<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0235">
 <label>46</label>
 <element-citation publication-type="journal" id="rf0225">
  <person-group person-group-type="author">
   <name>
    <surname>Rajah</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Sanchez</surname>
    <given-names>P.J.</given-names>
   </name>
   <name>
    <surname>Garcia-Maurino</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Leber</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ramilo</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Mejias</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Impact of the updated guidance for palivizumab prophylaxis against respiratory syncytial virus infection: a single center experience</article-title>
  <source>J Pediatr</source>
  <volume>181</volume>
  <year>2017</year>
  <fpage>183</fpage>
  <lpage>188</lpage>
  <comment>e1</comment>
  <pub-id pub-id-type="doi">10.1016/j.jpeds.2016.10.074</pub-id>
  <ext-link ext-link-type="uri" xlink:href="pmid:27855996" id="ir0310" xmlns:xlink="http://www.w3.org/1999/xlink">27855996</ext-link>
  <pub-id pub-id-type="pmid">27855996</pub-id>
 </element-citation>
</ref>
